Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02117440 · ClinicalTrials.gov registry record
Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer
A clinical trial, sponsored by Indiana University.
- Terminated
- Registry status
- 10
- Enrollment target
NCT02117440 is a clinical trial that was terminated before completion, run by Indiana University. The registered enrollment target is 10 participants.
The verdict
NCT02117440 was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
This study is designed to apply various scans such as functional imaging, Fluorodeoxyglucose\_Positron Emission Tomography (FDG-PET), 62Cu-ETS (Copper) PET, Ventilation/Perfusion Single Photon Emission Computerized Tomography (V/Q SPECT), cardiac magnetic resonance imaging (MRI), Tc-99m HMPAO SPECT/CT, and pulmonary function tests before, during and after treatment to see if it predicts how well the treatment works for your cancer and how well your lungs function during treatment. A Computerized Tomography (CT) will also be performed along with both of these procedures to help the researchers see clearly where your cancer or your healthy lung is located. The researchers also perform blood tests in this study to look for markers in your blood to see if it helps them determine your risk of developing side effects from radiation to the lungs. They will also measure your health-related quality of life before, during and after treatment. The researchers hope that this study will help them in the future to design radiation treatment plans that provide the best treatment for each individual patient.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2018-03-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02117440
The ClinicalTrials.gov registry entry for NCT02117440 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02117440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02117440 about?
NCT02117440 is a clinical study titled "Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer". This study is designed to apply various scans such as functional imaging, Fluorodeoxyglucose\_Positron Emission Tomography (FDG-PET), 62Cu-ETS (Copper) PET, Ventilation/Perfusion Single Photon Emission Computerized Tomography (V/Q SPECT), cardiac magnetic resonance imaging (MRI), Tc-99m HMPAO SPECT/...
What is the current status of trial NCT02117440?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2017-05-01. Estimated completion is 2018-03-02.
Who is sponsoring clinical trial NCT02117440?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.